OBIGAIL
LIVE

Serial Number

98797472

Owner

Avila Science, Inc.

Attorney

Mark A. Jansen

Filing Date

Oct 11, 2024

Add to watchlist:

No watchlists yet
View on USPTO

OBIGAIL Trademark

Serial Number: 98797472

OBIGAIL is a trademark filed by Avila Science, Inc. on October 11, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Avila Science, Inc. (2 trademarks)

114 Crosby Street, 7th Floor
New York, NY 10012

Entity Type: 03

Trademark Details

Filing Date

October 11, 2024

Registration Date

Not Registered

Published for Opposition

November 11, 2025

Goods & Services

Pharmaceutical and medical preparations for the treatment of early pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications; Pharmaceuticals for the management of early pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications

Healthcare services, namely, providing medical treatment in the fields of early pregnancy loss, miscarriage, infertility, and pregnancy complications; Healthcare services, namely, a patient assistance program providing pharmaceuticals for the treatment of pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications; Providing medical information in the field of pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications; Medical services; Pharmaceutical compounding services; Medical advisory services; Medical consultation and counseling services in the field of pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications; Medical consultations and therapy provided via website, phone, online chat or videoconferencing; Telemedicine services in the field of pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications; Women's health care and wellness services, namely, providing online information related to health care and wellness services; Preparation and dispensing of medications

Training services in the field of early pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications; Educational services, namely, conducting classes, seminars, conferences, and workshops in the field of early pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications; providing online non-downloadable articles, scientific papers, journals, brochures, leaflets, guides, manuals, videos, and multimedia content in the fields of reproduction, early pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications

Software as a service (SAAS) services featuring software using artificial intelligence (AI) for accessing health support services, accessing and receiving treatment, and communicating with healthcare professionals; software as a service (SAAS) services featuring software using agentic artificial intelligence (AI) for providing digital health services; software as a service (SAAS) services featuring software using agentic artificial intelligence (AI) for sending and receiving electronic messages, graphics, images, audio and audio visual content between healthcare professionals and individuals; Providing temporary use of online non-downloadable software using artificial intelligence (AI) for accessing health support services, accessing and receiving treatment, and communicating with healthcare professionals; Software as a service (SAAS) services featuring software for the provision of healthcare services; Providing temporary use of online non-downloadable software for use in connecting patients with health counseling providers, therapists, medical support resources, and information regarding treatment of early pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications; Providing temporary use of online non-downloadable software for accessing health support services, accessing and receiving treatment, and communicating with healthcare professionals; Providing temporary use of online non-downloadable software for sending and receiving electronic messages, graphics, images, audio and audio visual content between healthcare professionals and individuals; Providing temporary use of online non-downloadable software for facilitating medical consultancy services; Providing temporary use of online non-downloadable software for providing digital health services; Providing temporary use of online non-downloadable software for collecting, processing, and transmitting data between health care providers and patients; Providing temporary use of online non-downloadable software for enabling patients to view upcoming medical procedures, prepare for office visits, request medical tests, schedule and confirm medical appointments, and receive assistance with appointment logistics; Providing temporary use of online non-downloadable software for accessing information in the fields of reproduction, early pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications; Providing temporary use of online non-downloadable software using artificial intelligence technology for data analytics for use in connection with health counseling, therapy, support, and treatment; Providing temporary use of online non-downloadable software for managing the provision of healthcare services for use in the fields of reproduction, early pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications; Providing temporary use of online non-downloadable chatbot software using artificial intelligence (AI) in the fields of reproduction, early pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications; Providing temporary use of online non-downloadable software for medical research; Scientific and technological services, namely, research and development in the fields of reproduction, early pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications; Research and development of pharmaceuticals

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 6, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 11, 2025 NPUB
PUBLISHED FOR OPPOSITION
Nov 11, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 5, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 15, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 8, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 29, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 29, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jul 15, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jul 15, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 15, 2025 GNRN
NON-FINAL ACTION E-MAILED
Apr 15, 2025 GNRT
NON-FINAL ACTION WRITTEN
Apr 15, 2025 CNRT
ASSIGNED TO EXAMINER
Apr 15, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 14, 2025 NWOS
NEW APPLICATION ENTERED
Oct 11, 2024 NWAP